Shamburg News · 8-K filed Oct 23, 2026, 4:42 PM EDT
Ardent Health recharacterizes former CEO Bonick's separation as termination for cause
ARDT · Ardent Health, Inc.
- Leadership change
- Materiality: high
Ardent Health, Inc. reported that Martin J. Bonick's employment as President and Chief Executive Officer and his Board service ended effective June 2, 2026, under a Separation Agreement dated June 26, 2026. On October 19, 2026, the Board determined that facts discovered after the separation date would have supported termination for Cause, and the Company recharacterized the separation as a termination for Cause. The Company will discontinue remaining severance, including approximately $4.5 million of unpaid cash severance, and unvested PRSUs will be cancelled or forfeited; the Company reserved its rights to other remedies.
Source: SEC EDGAR, Form 8-K, Item 5.02, accession 0001104659-26-118499.
Written from the filing by Shamburg Markets. Figures are as reported by the company.